Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial.
Jeremy H PettusSchafer C BoederMark P ChristiansenDouglas S DenhamTimothy S BaileyHalis Kaan AkturkLeslie J KlaffJulio RosenstockMickie H M ChengBruce W BodeEdgar D BautistaRen XuHai YanDung ThaiSatish K GargSamuel KleinPublished in: Nature medicine (2023)